Drug Development Technology is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More X

Olcegepant – Novel Therapy for Acute Migraine

Patients with migraine can experience acute attacks in which the throbbing headache is preceded by a prodromal phase (migraine with aura) or occurs in the absence of a prodromal phase (migraine without aura). Attacks typically last 4-72 hours.


Go Top